Sawai Group Holdings
4887.TTSE PRIMEPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Silchester International Investors LLP | 7.91% |
| Nomura Asset Management Co., Ltd. | 6.46% |
| SOMPO ASSET MANAGEMENT CO., LTD. | 5.40% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 16
| Sumitomo Mitsui Trust Asset Management Co., Ltd. | 2.86% |
| JPMorgan Asset Management (Japan) Limited | 2.55% |
| SAWAKEN.Co.Ltd., | 2.27% |
| Kenzo Sawai | 1.99% |
| Nikko Asset Management Co., Ltd. | 1.67% |
| JPMorgan Asset Management (Asia Pacific) Limited | 1.48% |
| Hiroyuki Sawai | 1.46% |
| NOMURA INTERNATIONAL PLC | 0.49% |
| Setsuko Sawai | 0.35% |
| J.P. Morgan Securities LLC | 0.12% |
| JPMorgan Asset Management (China) Company Limited | 0.11% |
| Nomura Securities Co., Ltd. | 0.08% |
| JPMorgan Securities Japan Co., Ltd. | 0.07% |
| JPMorgan Asset Management (China) Company Limited | 0.05% |
| J.P. Morgan Securities plc | 0.03% |
| NOMURA SECURITIES INTERNATIONAL, Inc. | 0.00% |
Ownership history · 109
| Holder | Ratio | Change |
|---|---|---|
| Nomura Asset Management Co., Ltd.2024-02-05 · amended | 5.71% | new |
| J.P. Morgan Securities plc2024-02-05 · amended | 0.05% | new |
| J.P. Morgan Securities LLC2024-02-05 · amended | 0.20% | new |
| JPMorgan Asset Management (China) Company Limited2024-02-05 · amended | 0.21% | new |
| JPMorgan Securities Japan Co., Ltd.2024-02-05 · amended | 0.48% | new |
| JPMorgan Asset Management (Asia Pacific) Limited2024-02-05 · amended | 3.00% | new |
| JPMorgan Asset Management (Japan) Limited2024-02-05 · amended | 4.29% | new |
| Silchester International Investors LLP2024-02-01 · amended | 9.92% | -1.20pp |
| Silchester International Investors LLP2024-01-23 · amended | 11.12% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.